Simpson Associates officially named a 2022 UK’s Best Workplace™ in Tech!
“We hire great people who contribute both on a personal and technical level” is just…
“We hire great people who contribute both on a personal and technical level” is just…
MILPITAS, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — Zentry Security announces the immediate availability of…
SALT LAKE CITY, Sept. 28, 2022 (GLOBE NEWSWIRE) — Myriad Genetics (NASDAQ: MYGN), a leader in…
Centralized Procedure Allows for Submission of a Single Marketing Application to the European Medicines Agency…
AGOURA HILLS, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the…
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT),…
Presentations to highlight continued progress toward initiation of human clinical trials with novel DNA-damage response…
WALTHAM, Mass., Sept. 28, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (NASDAQ: CINC) today announced…
FORT LEE, Sept. 28, 2022 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical…
ZUG, Switzerland and BOSTON, Sept. 28, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a…
-Webinar to feature presentations from Rodney Rocconi, M.D. and John Nemunaitis, M.D., on Monday, October 3rd…
WILMETTE, Ill., Sept. 28, 2022 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage…
Facility to support clinical manufacturing for Vor Bio’s novel cell and genome engineering pipeline while…
WARREN, N.J., Sept. 28, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive”), a…
LONDON, Ontario, Sept. 28, 2022 (GLOBE NEWSWIRE) — Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage…
Twenty-four week interim analysis on approximately 160 subjects planned for Q1 2023 GAITHERSBURG, Md., Sept….
Velocity Clinical Research: The US Patient Survey 2022, Decentralization in Clinical Research. Dr G. Paul…
SOUTH ORANGE, NJ, Sept. 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Nephros, Inc. (Nasdaq:…
CALGARY, Alberta, Sept. 28, 2022 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX)…
Dr. Dreismann, Former Roche Molecular Diagnostics CEO, and Mr. Tibbitts, a Highly-accomplished Life-Sciences Executive, Provide…